SCM
FOMX

Sio Capital Management’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Sio Capital Management’s Portfolio FOMX Stock Details FOMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-920,796
Closed -$2.8M – 95
2019
Q3 		$2.8M Sell
920,796
-374,873
-29% -$1.05M 0.9% 40
2019
Q2 		$3.08M Hold
1,295,669
– – 0.74% 45
2019
Q1 		$4.86M Buy
1,295,669
+144,159
+13% +$540K 1.31% 27
2018
Q4 		$4.13M Buy
1,151,510
+381,510
+50% +$1.66M 1.51% 28
2018
Q3 		$4.41M Buy
+770,000
New +$4.4M 1.51% 25
2018
Q1 		– Sell
-131,200
Closed -$789K – 60
2017
Q4 		$789K Sell
131,200
-8,000
-6% -$48.1K 0.45% 39
2017
Q3 		$773K Hold
139,200
– – 0.4% 41
2017
Q2 		$646K Buy
+139,200
New +$621K 0.31% 52
2016
Q3 		– Sell
-405,374
Closed -$2.57M – 49
2016
Q2 		$2.57M Sell
405,374
-167,254
-29% -$1.11M 1.31% 27
2016
Q1 		$3.73M Buy
572,628
+156,656
+38% +$1.01M 1.37% 24
2015
Q4 		$3.37M Buy
415,972
+79,686
+24% +$596K 1.49% 22
2015
Q3 		$2.46M Buy
336,286
+175,000
+109% +$1.78M 1.69% 21
2015
Q2 		$1.65M Buy
+161,286
New +$1.78M 0.82% 32

Other funds holding FOMX

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

Sio Capital Management's FOMX Position: Q4 2019 in Review

Sio Capital Management sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q4 2019, closing a stake of 920,796 shares — an estimated $2.8M sold.

Sio Capital Management first reported a position in FOMX in Q2 2015 and held it in 13 quarters. The position peaked at $4.86M in Q1 2019. 65 funds tracked by Wall St. Rank hold FOMX as of Q4 2019.

  • Sio Capital Management reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q4 2019 after selling out during the quarter.
  • Sio Capital Management sold 920,796 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q4 2019, an estimated $2.8M.
  • Sio Capital Management first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q2 2015 and held it in 13 quarters.
  • Sio Capital Management's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $4.86M in Q1 2019.
  • 65 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q4 2019.

Based on Sio Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.